We have shown that anti-fluorescein CAR-T cells (FL-CAR-T cells) can target multiple antigens including EGFR, HER2, and CD38 expressed on the surface of the breast cancer, ovarian cancer, Burkitt lymphoma, and multiple myeloma cells. This evidence concerns the gene EGFR and plasma cell myeloma.